We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App





New Coronavirus Test Works 10 Times Faster

By LabMedica International staff writers
Posted on 14 Apr 2020
A new testing method for COVID-19 can confirm the presence of the virus 4-10 times faster than the current method of extracting ribonucleic acid (RNA) molecules from a patient’s swab sample to see whether they contain viral RNA. More...
In addition to being equally accurate, the new test does not use specially produced test kits or reagents needed for extracting RNA and instead uses materials commonly found in diagnostic labs, thus making it significantly cheaper and reducing dependence on imported testing materials.

The new testing method for COVID-19 has been developed by researchers from the Hebrew University of Jerusalem (Jerusalem, Israel). The COVID-19 testing kits currently in use extract RNA molecules from a patient's sample to determine if they have viral RNA within them to confirm the presence of the coronavirus. However, these test kits require testing materials, such as complex reagents to extract the RNA for analysis, which are in short supply globally, thus slowing down the rate of testing and increasing the rate of infection.

The Hebrew University researchers have devised a new COVID-19 testing method using a homemade solution that is more easily available and cheaper than the kits. Instead of complex reagents, their test uses tiny magnetic beads to extract RNA for analysis and can be performed both robotically as well as manually. The beads are also recyclable and can be reused to perform future tests. The method was tested on hundreds of samples and all the tests came out identical to the results obtained using the current test kits. The bead method extracted RNA is also ready for analysis four to 10 times more quickly than most other methods.

The researchers believe if their COVID-19 testing method can help labs significantly eliminate the testing bottleneck by reducing their dependence on external factors. The researchers are now developing a method based on genomic sequencing tools that will allow tens of thousands of samples to be tested simultaneously instead of the current rate of thousands of tests.

Related Links:
The Hebrew University of Jerusalem

Platinum Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
SARS-CoV-2 Antibody Test
SARS-CoV-2 UTAB FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.